The global Paper diagnostics market size is anticipated to around USD 11.0 billion by 2026, this market is anticipated to grow with 8.3% CAGR during the forecast time period. The market is driven by increasing government initiatives to encourage progressive diagnosis for infectious diseases. Also, increase in demand for better diagnostic solution also driving the growth of the market.
Growing demand for cost-effective healthcare in remote areas of emerging nations is foremost to increasing popularity of point-of-care diagnostic approaches in these nations. Furthermore, in developed nations, heightened acceptance of point-of-care diabetes test kits and pregnancy test kits is anticipated to work in favour of the industry.
Growing occurrence of diseases for instance, autoimmune diseases, cancer, and inflammatory diseases is one of the main parameters anticipated to drive the need for novel and speedy diagnostics procedures, thus boosting the market during the forecast timeframe. Such as, as per the American Cancer Society, in 2018, about 1.7 million new cancer cases are expected to be identified and 609,640 individuals are expected to die owing to cancer. The numeral of cancer cases is anticipated to increase by about 70.0% over the next two decades. This trend is expected to aid the market gain momentum during the forecast timeframe.
Introduction of technically advanced paper based diagnostic products, which bid sensitive and rapid results, is expected to increase industry development over the forecast timeframe. Growth of paper-based ELISA for detection of autoimmune antibodies in body fluid is anticipated to boost the need for technically progressive & upgraded lateral flow assays over the forecast timeframe. Lateral flow assays held an important share in the market in 2018, due to extensive application in disease diagnostics and related benefits for instance, robust & rapid results, ease of use, sensitivity, and cost efficiency.
Market By Product
Market By End-user
Market By Device Type
Market By Application
Market By Geography
In 2018, North America was the most important regional market, due to growing need for self-testing devices paired with well-established healthcare infrastructure. Market players are involved in R&D activities to cost efficient, develop accurate, and sensitive paper based microfluidics. Emphasis on mergers and acquisitions, constant system upgradation through R&D investments and fund rising are some of the key strategies accepted by market participants.
Market companies are concentrating on implementing new strategies for instance regional expansion, partnerships, mergers and acquisitions, new product launches, and distribution agreements to surge their revenue share. The major players associated with the Paper diagnostics market are Abbott, Bio-Rad Laboratories, Acon Laboratories, Inc., Siemens healthcare, ARKRAY Inc., Abcam Plc, and Abingdon Health.
Introduction ECG Equipment and Management Systems is a gadget which records the heart exercises through electric signals and are enhanced on the ECG screen. ECG Equipment and Management Systems are utilized to analyze sorts of heart illnesses and arrhythmias in an individual's body in this manner help the suitable treatment. The ECG test is noninvasive and effortless method and decides irregularity designs
Introduction Ear, nose and throat are some of the most vital parts of the human body. It is very important to keep the functions of these parts properly. There are many factors that affect the normal functioning of these organs such as sinusitis and aging. ENT, a prominent amongst the most vital parts of medical science is basically focusing on diagnosis and treatment of the different issues related with e
Introduction The global macular degeneration treatment Market is estimated to value US$ 11.4 Billion by 2026 and the market is projected to showcase 6.6% CAGR during the forecast period. The macular degeneration treatment market is driven by surge in healthcare spending and improved in healthcare infrastructure. Market D
Introduction The world-wide Anticoagulants market is expected to garner USD 39 billion by 2026 and the market is expected to register CAGR growth over 7.9% during the next eight years. Market Dynamics Growing need for controlling the diseases such as kidney diseases and cardi
Introduction The global Gynecological Devices market was valued at $9.4 billion in 2018 and is anticipated to grow at a CAGR of 7.9% during the forecast period. Gynecological devices include instruments and devices used for the treatment of diseases related to the female reproductive system. These devices include surgical devices, handheld instruments, diagnostic i
Introduction The international transfusion technology market’s worth is likely to touch USD 7,138 Million by 2026 and the market is expected to project a CAGR of 5.4% during the upcoming years. Market Dynamics The worldwide transfusion technology market is described by